Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Latest filing published 24 Apr 2026 for Pacira BioSciences, Inc., €182k. Read the official filing
Filing timeline
BuySaleShawn Cross
Insider track record
Disclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Shawn Cross: trading record in brief
Shawn Cross is a declared insider at 3 companies (finance chief); the most frequent names are Applied Molecular Transport Inc., Pacira BioSciences, Inc. and Cyclo Therapeutics, Inc. In total, 31 filings cover trades dated from 19 August 2021 to 23 April 2026.
Every open-market trade on record is a sale: 12 sales worth €807k. Other entries cover 12 share grants and 6 option exercises. 2026 to date brings no purchases and 4 sales.
The latest filing, published on 24 April 2026, reports an option exercise of €182k in Pacira BioSciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Shawn Cross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
12,941 shares@ US$16.450.021% mcap39.5% of flowCommon StockSEC:0001628280-26-027287:0
12,941 shares@ US$25.160.032% mcap60.5% of flowCommon StockSEC:0001628280-26-027287:1
7,714 shares@ US$16.450.012% mcap12.1% of flowCommon StockSEC:0001628280-26-026669:0
7,714 shares@ US$25.140.019% mcap18.6% of flowCommon StockSEC:0001628280-26-026669:1
2,845 shares@ US$16.450.0045% mcap4.5% of flowCommon StockSEC:0001628280-26-026669:2
2,845 shares@ US$25.010.0069% mcap6.8% of flowCommon StockSEC:0001628280-26-026669:3
1,500 shares@ US$16.450.0024% mcap2.4% of flowCommon StockSEC:0001628280-26-026669:4
1,500 shares@ US$25.010.0037% mcap3.6% of flowCommon StockSEC:0001628280-26-026669:5
49,091 shares0Common StockSEC:0001628280-26-008080:0
15,896 shares@ US$16.4515.3% of flowCommon StockSEC:0001628280-25-056645:0
12,060 shares@ US$22.0918.6% of flowCommon StockSEC:0001628280-25-052038:0
6,690 shares@ US$21.3812.2% of flowCommon StockSEC:0001628280-25-048393:0
28,597 shares0Common StockSEC:0001437749-25-005850:0
17,228 shares0Common StockSEC:0001437749-24-035588:0
75,000 shares0Common StockSEC:0001396814-24-000135:0
9,028 shares0Common StockSEC:0001437749-24-027329:0
8,887 shares0Common StockSEC:0001437749-24-019344:0
72,606 shares0Common StockSEC:0001437749-23-035527:0
545,499 sharesCommon StockSEC:0001209191-23-059929:0
110,802 shares@ US$0.163538.6% of flowCommon StockSEC:0001209191-23-056587:0
90,447 shares@ US$0.160631.1% of flowCommon StockSEC:0001209191-23-055560:0
3,293 shares@ US$0.24121.7% of flowCommon StockSEC:0001209191-23-052122:0
886,111 shares0Common StockSEC:0001209191-23-051217:0
934 shares@ US$0.501.0% of flowCommon StockSEC:0001209191-23-015778:0
3,893 shares@ US$1.05019.0% of flowCommon StockSEC:0001209191-22-060031:0
25 of 31 declarations
